QUÉBEC CITY and MYRTLE BEACH, SC, Aug. 12, 2019 /PRNewswire/ – TSO3 Inc. (“TSO3” or the “Company“) (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has entered into a definitive arrangement agreement (the “Arrangement Agreement“) pursuant to which 9402-4874 Québec Inc. (the “Purchaser“), a subsidiary of Stryker Corporation (“Stryker“), will acquire all of the issued and …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone